Blue Bell Private Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-31
Closed -$642 708
2024
Q2
$642 Hold
31
﹤0.01% 686
2024
Q1
$583 Hold
31
﹤0.01% 702
2023
Q4
$447 Hold
31
﹤0.01% 705
2023
Q3
$538 Hold
31
﹤0.01% 659
2023
Q2
$645 Sell
31
-182
-85% -$3.96K ﹤0.01% 665
2023
Q1
$5.01K Hold
213
﹤0.01% 461
2022
Q4
$5.95K Buy
213
+7
+3% +$179 ﹤0.01% 441
2022
Q3
$5K Hold
206
﹤0.01% 472
2022
Q2
$7K Hold
206
﹤0.01% 449
2022
Q1
$7K Sell
206
-92
-31% -$3.15K ﹤0.01% 492
2021
Q4
$9K Buy
+298
New +$9.71K ﹤0.01% 425

Other funds holding OGN

Blue Bell Private Wealth Management's OGN Position: Q3 2024 in Review

Blue Bell Private Wealth Management sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 31 shares — an estimated $642 sold.

Blue Bell Private Wealth Management first reported a position in OGN in Q4 2021 and held it in 11 quarters. The position peaked at $9K in Q4 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Blue Bell Private Wealth Management reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 31 Organon & Co shares in Q3 2024, an estimated $642.
  • Blue Bell Private Wealth Management first reported a position in Organon & Co in Q4 2021 and held it in 11 quarters.
  • Blue Bell Private Wealth Management's Organon & Co position peaked at $9K in Q4 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Blue Bell Private Wealth Management's 13F filing for Q3 2024, filed 29 Oct 2024.